When to Adjust Your Eating Strategy with PlexusDx Everyone's digestive system responds differently to semaglutide, and your genetic makeup influences how your body processes appetite-regulating peptides
Type 2 diabetes is a condition where the body either does not produce enough insulin or does not use insulin effectively, leading to high blood sugar levels
In the SURMOUNT-1 trial, participants following this dosing protocol achieved mean weight reductions of 15.0% (5 mg dose), 19.5% (10 mg dose), and 20.9% (15 mg dose) at 72 weeks, compared to 3.1% with placebo
Instead, theyve become a major driver of higher prices
There is no regulatory requirement for a universal concentration
The scientific community has shown increasing interest in the potential neuroprotective properties of GLP-1 receptor agonists, with research extending beyond their established metabolic benefits